A head-to-head comparison between the VerifyNow P2Y12 assay and light transmittance aggregometry for monitoring the individual platelet response to clopidogrel in patients undergoing elective percutaneous coronary intervention.
van Werkum
J W
JW
van der Stelt
C A K
CA
Seesing
T H
TH
Hackeng
C M
CM
ten Berg
J M
JM
D015906:Angioplasty, Balloon, Coronary; D000077144:Clopidogrel; D016903:Drug Monitoring / Q000379:methods; D017558:Elective Surgical Procedures; D005260:Female; D006801:Humans; D008297:Male; D010974:Platelet Aggregation / Q000187:drug effects*; D010975:Platelet Aggregation Inhibitors / Q000494:pharmacology*; D010979:Platelet Function Tests / Q000379:methods; D011446:Prospective Studies; D011933:Reagent Kits, Diagnostic; D018048:Receptors, Purinergic P2 / Q000737:chemistry*; D058473:Receptors, Purinergic P2Y2; D015203:Reproducibility of Results; D015607:Stents; D013988:Ticlopidine / Q000031:analogs & derivatives* / Q000494:pharmacology
C546385:P2RY2 protein, human; D010975:Platelet Aggregation Inhibitors; D011933:Reagent Kits, Diagnostic; D018048:Receptors, Purinergic P2; D058473:Receptors, Purinergic P2Y2; D000077144:Clopidogrel; D013988:Ticlopidine